Cancer - Advances, Knowledge, Integrative & Holistic Treatments

A study of 14,000 cancer patients in the Netherlands found that regular users of aspirin were twice as likely to still be alive after a four-year period as those who did not take the cheap drug. The most common tumor sites for patients in the study were the colon, rectum and esophagus.

The study concludes that a daily dose of aspirin can double the life expectancy of patients with cancers affecting the gastrointestinal tract.